Australian & New Zealand Childrens Haematology/Oncology Group
Study Title
A Phase I Study of the Safety and Pharmacokinetics of Venetoclax in Paediatric and Young Adult Patients with Relapsed or Refractory Malignancies
Protocol ID
M13-833
Disease (Sub Disease)
Leukaemia (ALL/AML)
Diagnosis Stage
Relapse/ refractory
Sponsor
AbbVie
Collaborators
Roche-Genentech
Links
Trial Status
Closed to Recruitment
Study Type
Treatment
Phase
Phase 1
Age Eligibility
up to 25 years
International registry ID's
NCT03236857
| Study Title | A Phase I Study of the Safety and Pharmacokinetics of Venetoclax in Paediatric and Young Adult Patients with Relapsed or Refractory Malignancies |
|---|---|
| Protocol ID | M13-833 |
| Disease (Sub Disease) | Leukaemia (ALL/AML) |
| Diagnosis Stage | Relapse/ refractory |
| Sponsor | AbbVie |
| Collaborators | Roche-Genentech |
| Links | https://clinicaltrials.gov/ct2/show/NCT03236857 |
| Trial Status | Closed to Recruitment |
| Trial Open Date | 17/08/2017 |
| Study Type | Treatment |
| Phase | Phase 1 |
| Age Eligibility | up to 25 years |
| International registry ID's | NCT03236857 |